Seattle · Hybrid · $150k–$180k/yr
Outpost
About Outpost
The company aims to build the backbone of US freight logistics. It uses a connected network of semi-truck and trailer parking. The company operates in the United States freight logistics market.
Open positions · 10
Remote solely
Austin · On-site
Chicago · Remote ok
Remote solely
Remote solely · $75k–$90k/yr
Seattle · Remote solely
Austin · On-site · $150k–$180k/yr
Austin · On-site
Seattle · Hybrid · $150k–$180k/yr
Company at a glance
Investors
Location
Funding History
$12.5M
raised
Outpost, a managed semi-truck parking network, raised a $12.5M Series A led by GreenPoint Partners with support from Speedwagon Capital Partners.
Life at Outpost
Frequently asked questions
Companies similar to Outpost
PAXAFE provides end-to-end shipment visibility via its platform. This depth of insight enables proactive exception management and operational optimization for logistics teams across the supply chain. By delivering proactive issue detection and streamlined operations, PAXAFE helps logistics teams across the supply chain manage risks more effectively.
Zauber is building the AI operating system for logistics. Global supply chains still run on email and spreadsheets. Zauber's self-learning agents read, reason, and act inside freight forwarding workflows, so operators get hours back each day.
Aira is an AI platform designed for procedural specialties that serves as the payer intelligence layer for medical device companies and surgical practices. The company automates critical back-office workflows while handling the full payer compliance lifecycle, including benefits verification, medical necessity determinations, prior authorization, and appeals management. By functioning as the intelligence layer powering market access teams, Aira helps healthcare providers and device manufacturers navigate the complexity of reimbursement processes to increase patient access to needed procedures. The platform addresses a key pain point in healthcare operations by streamlining the administrative burden that often delays care and complicates market entry for medical innovations.

